Timmer C - Search Results

1

Asenapine Safety, Tolerability, and Pharmacokinetics After Single and Multiple Doses in Healthy Volunteers.

Dogterom P, Timmer C, de Greef R, Spaans E, de Vries D, van Vliet A, Peeters P. Dogterom P, et al. Among authors: timmer c. Clin Pharmacol Drug Dev. 2012 Oct;1(4):131-43. doi: 10.1177/2160763X12455328. Clin Pharmacol Drug Dev. 2012. PMID: 27121455

2

Pharmacokinetics and biotransformation of mirtazapine in human volunteers.

Delbressine LP, Moonen ME, Kaspersen FM, Wagenaars GN, Jacobs PL, Timmer CJ, Paanakker JE, van Hal HJ, Voortman G. Delbressine LP, et al. Among authors: timmer cj. Clin Drug Investig. 1998;15(1):45-55. doi: 10.2165/00044011-199815010-00006. Clin Drug Investig. 1998. PMID: 18370465

3

Pharmacokinetic parameters of sulfated tibolone metabolites in postmenopausal women after single and multiple doses of tibolone.

Verheul HA, Timmer CJ, Kloosterboer HJ. Verheul HA, et al. Among authors: timmer cj. Clin Pharmacol Ther. 2007 Apr;81(4):573-9. doi: 10.1038/sj.clpt.6100094. Epub 2007 Feb 14. Clin Pharmacol Ther. 2007. PMID: 17301737 Clinical Trial.

4

Concomitant use of mirtazapine and cimetidine: a drug-drug interaction study in healthy male subjects.

Sitsen JM, Maris FA, Timmer CJ. Sitsen JM, et al. Among authors: timmer cj. Eur J Clin Pharmacol. 2000 Aug;56(5):389-94. doi: 10.1007/s002280000174. Eur J Clin Pharmacol. 2000. PMID: 11009047 Clinical Trial.

5

Pharmacokinetics of tibolone in early and late postmenopausal women.

Timmer CJ, Verheul HA, Doorstam DP. Timmer CJ, et al. Br J Clin Pharmacol. 2002 Aug;54(2):101-6. doi: 10.1046/j.1365-2125.2002.01619.x. Br J Clin Pharmacol. 2002. PMID: 12207627 Free PMC article. Clinical Trial.

6

Drug-drug interaction studies with mirtazapine and carbamazepine in healthy male subjects.

Sitsen J, Maris F, Timmer C. Sitsen J, et al. Among authors: timmer c. Eur J Drug Metab Pharmacokinet. 2001 Jan-Jun;26(1-2):109-21. doi: 10.1007/BF03190384. Eur J Drug Metab Pharmacokinet. 2001. PMID: 11554425 Clinical Trial.

7

Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers.

Oberyé JJ, Mannaerts BM, Huisman JA, Timmer CJ. Oberyé JJ, et al. Among authors: timmer cj. Fertil Steril. 1999 Dec;72(6):1006-12. doi: 10.1016/s0015-0282(99)00414-8. Fertil Steril. 1999. PMID: 10593372 Free article. Clinical Trial.

8

Clinical pharmacokinetics of mirtazapine.

Timmer CJ, Sitsen JM, Delbressine LP. Timmer CJ, et al. Clin Pharmacokinet. 2000 Jun;38(6):461-74. doi: 10.2165/00003088-200038060-00001. Clin Pharmacokinet. 2000. PMID: 10885584 Review.

9

Pharmacokinetics of mirtazapine and lithium in healthy male subjects.

Sitsen JM, Voortman G, Timmer CJ. Sitsen JM, et al. Among authors: timmer cj. J Psychopharmacol. 2000 Jun;14(2):172-6. doi: 10.1177/026988110001400207. J Psychopharmacol. 2000. PMID: 10890312 Clinical Trial.

10

Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part I. Absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers.

Oberyé JJ, Mannaerts BM, Kleijn HJ, Timmer CJ. Oberyé JJ, et al. Among authors: timmer cj. Fertil Steril. 1999 Dec;72(6):1001-5. doi: 10.1016/s0015-0282(99)00413-6. Fertil Steril. 1999. PMID: 10593371 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters